Skip to content

Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality

Risk Factor of Acute Kidney Injury After Open Heart Surgery With Cardiopulmonary Bypass

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02916043
Enrollment
1099
Registered
2016-09-27
Start date
2016-04-30
Completion date
2016-11-30
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

acute kidney injury, cardiovascular surgery, mortality

Brief summary

Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Detailed description

Acute kidney injury (AKI) after cardiovascular surgery remains a serious complication associated with increased mortality for up to 10 years. The incidence of AKI after cardiovascular surgery is as high as 55% and the incidence of renal replacement therapy (RRT) to be up to 8 %. Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Interventions

Patients who underwent cardiovascular surgery including valve replacement or thoracic aortic surgery with cardiopulmonary bypass

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass (CPB), including valve replacement and surgery on the thoracic aorta at the Seoul National University Hospital between 2007 and 2015

Exclusion criteria

* Missing preoperative serum creatinine (sCr) values * Missing preoperative platelet, neutrophil and lymphocyte counts * Patients who underwent preoperative hemodialysis

Design outcomes

Primary

MeasureTime frameDescription
Acute kidney injurypostoperative day sevenacute kidney injury during postoperative seven days defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria

Secondary

MeasureTime frameDescription
All-cause mortalitypostoperative seven yearsall-cause mortality after cardiovascular surgery after postoperative seven years

Other

MeasureTime frameDescription
Postoperative length of hospital staypostoperative two monthpostoperative length of hospital stay
Postoperative length of ICU staypostoperative two monthspostoperative length of ICU stay during postoperative two months
Postoperative incidence of complicationspostoperative two monthspostoperative incidences of surgery-related complications during hospital stay

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026